体外膜肺氧合在新型冠状病毒肺炎中的应用价值

Utility of extracorporeal membrane oxygenation in COVID-19.

作者信息

Khan Rizwan, Anandamurthy Balaram, McCurry Kenneth, Krishnan Sudhir

机构信息

Department of Critical Care Medicine, Respiratory Institute, Heart, Vascular, and Thoracic Institute, Cleveland Clinic.

Department of Cardiothoracic Anesthesiology, Heart, Vascular, and Thoracic Institute, Cleveland Clinic.

出版信息

Cleve Clin J Med. 2020 May 5. doi: 10.3949/ccjm.87a.ccc014.

DOI:10.3949/ccjm.87a.ccc014

PMID:32371555

Abstract

Extracorporeal membrane oxygenation (ECMO) is a means of cardiopulmonary support for refractory respiratory and cardiac failure. ECMO is a resource-intensive therapy that can be considered in highly selected patients. Expert centers should employ an evidence-based ARDS treatment algorithm and a multidisciplinary approach to recommending ECMO upon failure of conventional therapy. Caring for ECMO patients requires adequate infection control and safety precautions for healthcare workers.

摘要

体外膜肺氧合（ECMO）是一种用于治疗难治性呼吸和心力衰竭的心肺支持手段。ECMO是一种资源密集型治疗方法，仅适用于经过严格筛选的患者。专家中心应采用基于证据的急性呼吸窘迫综合征（ARDS）治疗算法，并采用多学科方法，在传统治疗失败后推荐使用ECMO。护理ECMO患者需要对医护人员采取充分的感染控制和安全预防措施。